Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Lymphomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03062072
What this trial is testing

Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients

Who this might be right for
CancerColon CancerBreast Cancer+1 more
National Cancer Center, Korea 300
Testing effectiveness (Phase 2)Study completedNCT00389077
What this trial is testing

Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas

Who this might be right for
TumorsLymphomas
AEterna Zentaris 558
Testing effectiveness (Phase 2)Looking for participantsNCT06678659
What this trial is testing

REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

Who this might be right for
UnresectableLocally AdvancedMetastatic Cancers+1 more
Recursion Pharmaceuticals Inc. 170
Early research (Phase 1)Looking for participantsNCT07082803
What this trial is testing

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

Who this might be right for
LymphomaLymphoma, Non Hodgkin
Treeline Biosciences, Inc. 180
Post-approval studies (Phase 4)UnknownNCT05545202
What this trial is testing

A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation

Who this might be right for
Malignant LymphomaMultiple Myeloma
Pharmacosmos A/S 150
Testing effectiveness (Phase 2)Study completedNCT00683046
What this trial is testing

T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies

Who this might be right for
Acute Myelogenous LeukemiaLymphoid LeukemiaChronic Myelogenous Leukemia+6 more
University of Chicago 204
Early research (Phase 1)WithdrawnNCT04372641
What this trial is testing

Testing the Safety of CB-5339 in Patients With Cancer

Who this might be right for
Aggressive Non-Hodgkin LymphomaIndolent Non-Hodgkin LymphomaLocally Advanced Malignant Solid Neoplasm+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01403896
What this trial is testing

Healthy Donor Study II - Comparing Plerixafor With G-CSF and Plerixafor

Who this might be right for
Malignant Lymphoma, Stem Cell Type
Stephen Couban 10
Not applicableStudy completedNCT00856388
What this trial is testing

Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+97 more
Roswell Park Cancer Institute 62
Not applicableUnknownNCT06424379
What this trial is testing

BCL6-rearrangements Implications in Non-Hodgkin Lymphomas.

Who this might be right for
Non Hodgkin LymphomaFollicular LymphomaMarginal Zone Lymphoma+1 more
Hospices Civils de Lyon 135
Early research (Phase 1)Active Not RecruitingNCT04013685
What this trial is testing

Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMyelodysplastic Syndromes+3 more
Orca Biosystems, Inc. 155
Not applicableStudy completedNCT04132843
What this trial is testing

Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions

Who this might be right for
Brain NeoplasmLymphomaMetastatic Malignant Neoplasm in the Brain+1 more
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Ended earlyNCT03983668
What this trial is testing

CMP-001 for Relapsed and Refractory Lymphoma

Who this might be right for
Lymphoma
Umar Farooq 14
Not applicableStudy completedNCT00248547
What this trial is testing

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

Who this might be right for
Cancer
OHSU Knight Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT00003784
What this trial is testing

S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 102
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07505849
What this trial is testing

ZR2 Versus R2 Regimen in the Treatment of Newly Diagnosed Follicular Lymphoma

Who this might be right for
Follicular Lymphomas
KeshuZhou 100
Testing effectiveness (Phase 2)Looking for participantsNCT06292208
What this trial is testing

A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors

Who this might be right for
MTD
SUNHO（China）BioPharmaceutical CO., Ltd. 48
Testing effectiveness (Phase 2)UnknownNCT05598268
What this trial is testing

T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.

Who this might be right for
Advanced Solid TumorLung CancerLiver Cancer+2 more
ImmVira Pharma Co. Ltd 74
Testing effectiveness (Phase 2)Study completedNCT00118326
What this trial is testing

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390826
What this trial is testing

Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 10
Next Page